J. Biochem, 2004, Vol. 136, No. 3 279-282
© 2004 The Japanese Biochemical Society
CELL |
Abundant Retention and Release of Connective Tissue Growth Factor (CTGF/CCN2) by Platelets
1 Department of Biochemistry and Molecular Dentistry, Okayama University Graduate School of Medicine and Dentistry, Okayama 700-8525; and 2 Biosciences Research & Development Center, Nichirei Corporation, Tokyo 180-0003
Wound healing and tissue regeneration are usually initiated by coagulation followed by fibrous tissue formation. In the present study, we discovered an abundance of connective tissue growth factor (CTGF/CCN2) in human platelets, which was released along with the coagulation process. The CTGF/CCN2 content in platelets was 10-fold higher than that in arterial tissue. Furthermore, the CTGF/CCN2 content in a single platelet was computed to be more than 20-fold higher than that of any other growth factor reported. Considering that CTGF/CCN2 promotes angiogenesis, cartilage regeneration, fibrosis and platelet adhesion, it may be now regarded as one of the major functional components of platelets.
* To whom correspondence should be addressed. Tel: +81-86-235-6646, Fax: +81-86-235-6649, E-mail: takigawa{at}md.okayama-u.ac.jp
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. A. Black Jr. and P. C. Trackman Transforming Growth Factor-{beta}1 (TGF{beta}1) Stimulates Connective Tissue Growth Factor (CCN2/CTGF) Expression in Human Gingival Fibroblasts through a RhoA-independent, Rac1/Cdc42-dependent Mechanism: STATINS WITH FORSKOLIN BLOCK TGF{beta}1-INDUCED CCN2/CTGF EXPRESSION J. Biol. Chem., April 18, 2008; 283(16): 10835 - 10847. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Agren and M. Werthen The Extracellular Matrix in Wound Healing: A Closer Look at Therapeutics for Chronic Wounds International Journal of Lower Extremity Wounds, June 1, 2007; 6(2): 82 - 97. [Abstract] [PDF] |
||||
![]() |
M. S. Ahmed, E. Oie, L. E. Vinge, T. G. von Lueder, T. Attramadal, and H. Attramadal Induction of pulmonary connective tissue growth factor in heart failure is associated with pulmonary parenchymal and vascular remodeling Cardiovasc Res, May 1, 2007; 74(2): 323 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gressner, E. Yagmur, B. Lahme, O. Gressner, and S. Stanzel Connective Tissue Growth Factor in Serum as a New Candidate Test for Assessment of Hepatic Fibrosis Clin. Chem., September 1, 2006; 52(9): 1815 - 1817. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kondo, N. Tanaka, S. Kubota, Y. Mukudai, G. Yosimichi, T. Sugahara, and M. Takigawa Novel angiogenic inhibitor DN-9693 that inhibits post-transcriptional induction of connective tissue growth factor (CTGF/CCN2) by vascular endothelial growth factor in human endothelial cells Mol. Cancer Ther., January 1, 2006; 5(1): 129 - 137. [Abstract] [Full Text] [PDF] |
||||




